[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2004033215A5 - - Google Patents

Download PDF

Info

Publication number
JP2004033215A5
JP2004033215A5 JP2003096170A JP2003096170A JP2004033215A5 JP 2004033215 A5 JP2004033215 A5 JP 2004033215A5 JP 2003096170 A JP2003096170 A JP 2003096170A JP 2003096170 A JP2003096170 A JP 2003096170A JP 2004033215 A5 JP2004033215 A5 JP 2004033215A5
Authority
JP
Japan
Prior art keywords
microarray
kit
diagnostic
diagnostic portfolio
portfolio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003096170A
Other languages
English (en)
Other versions
JP4409845B2 (ja
JP2004033215A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2004033215A publication Critical patent/JP2004033215A/ja
Publication of JP2004033215A5 publication Critical patent/JP2004033215A5/ja
Application granted granted Critical
Publication of JP4409845B2 publication Critical patent/JP4409845B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項1】 配列番号1〜30、32、34及び98から成る群から選択された遺伝子の組み合わせにおける単離された核酸配列、それらの相補体、又はそれらの一部を含んで成る診断ポートフォリオ。
【請求項2】 そこに含まれる遺伝子の示差的発現を同定するために適切なマトリックスにおける請求項1記載の診断ポートフォリオ。
【請求項3】 前記マトリックスがマイクロアレイにおいて使用される請求項2記載の診断ポートフォリオ。
【請求項4】 前記マイクロアレイがcDNAマイクロアレイである請求項3記載の診断ポートフィリオ。
【請求項5】 前記マイクロアレイがオリゴヌクレオチドマイクロアレイである請求項3記載の診断ポートフォリオ。
【請求項6】 配列番号32〜67、69及び98〜100から成る群から選択された遺伝子の組み合わせにおける単離された核酸配列、それらの相補体、又はそれらの一部を含んで成る診断ポートフォリオ。
【請求項7】 そこに含まれる遺伝子の示差的発現を同定するために適切なマトリックスにおける請求項6記載の診断ポートフォリオ。
【請求項8】 前記マトリックスがマイクロアレイにおいて使用される請求項7記載の診断ポートフォリオ。
【請求項9】 前記マイクロアレイがcDNAマイクロアレイである請求項8記載の診断ポートフィリオ。
【請求項10】 前記マイクロアレイがオリゴヌクレオチドマイクロアレイである請求項8記載の診断ポートフォリオ。
【請求項11】 配列番号1〜30、32、34及び98から成る群から選択された遺伝子の組み合わせの発現の検出のための試薬を含んでなる、癌診断用キット。
【請求項12】 マイクロアレイ分析を行なうための試薬を更に含んでなる請求項11記載のキット。
【請求項13】 前記遺伝子内の核酸配列、それらの相補体、またはそれらの部分をアッセイするための媒体を更に含んでなる請求項11記載のキット。
【請求項14】 前記媒体がマイクロアレイである請求項13記載のキット。
【請求項15】 使用説明書を更に含んでなる請求項11記載のキット。
【請求項16】 配列番号32〜67、69及び98〜100から成る群から選択された遺伝子の発現の検出のための試薬を含んでなる、癌診断用キット。
【請求項17】 マイクロアレイ分析を行なうための試薬を更に含んでなる請求項16記載のキット。
【請求項18】 前記遺伝子内の核酸配列、それらの相補体、またはそれらの部分をアッセイするための媒体を更に含んでなる請求項16記載のキット。
【請求項19】 前記媒体がマイクロアレイである請求項18記載のキット。
【請求項20】 使用説明書を更に含んでなる請求項19記載のキット。
JP2003096170A 2002-03-29 2003-03-31 癌診断パネル Expired - Fee Related JP4409845B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36866702P 2002-03-29 2002-03-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009049600A Division JP2009118855A (ja) 2002-03-29 2009-03-03 癌診断パネル

Publications (3)

Publication Number Publication Date
JP2004033215A JP2004033215A (ja) 2004-02-05
JP2004033215A5 true JP2004033215A5 (ja) 2006-03-23
JP4409845B2 JP4409845B2 (ja) 2010-02-03

Family

ID=28675523

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003096170A Expired - Fee Related JP4409845B2 (ja) 2002-03-29 2003-03-31 癌診断パネル
JP2009049600A Pending JP2009118855A (ja) 2002-03-29 2009-03-03 癌診断パネル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009049600A Pending JP2009118855A (ja) 2002-03-29 2009-03-03 癌診断パネル

Country Status (10)

Country Link
US (2) US7348142B2 (ja)
EP (1) EP1355150A3 (ja)
JP (2) JP4409845B2 (ja)
KR (1) KR20030078799A (ja)
CN (2) CN100577813C (ja)
AR (1) AR039210A1 (ja)
AU (1) AU2003203553A1 (ja)
BR (1) BR0303011A (ja)
CA (1) CA2422319A1 (ja)
MX (1) MXPA03002862A (ja)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360073C (en) * 1999-01-28 2011-01-18 Gen-Probe Incorporated Probes and primers for detecting prostate specific antigen (psa) in a biological sample
US7348142B2 (en) * 2002-03-29 2008-03-25 Veridex, Lcc Cancer diagnostic panel
EP1361433A3 (en) * 2002-04-09 2005-02-23 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20040191782A1 (en) * 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
CA2475769C (en) * 2003-08-28 2018-12-11 Veridex, Llc Colorectal cancer prognostics
WO2005054508A2 (en) * 2003-12-01 2005-06-16 Ipsogen Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
EP1913503A1 (en) * 2005-08-05 2008-04-23 Koninklijke Philips Electronics N.V. Search space coverage with dynamic gene distribution
US20080050726A1 (en) * 2005-09-19 2008-02-28 Yixin Wang Methods for diagnosing pancreatic cancer
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
WO2007081387A1 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices, methods of use, and kits for performing diagnostics
MX2008011356A (es) * 2006-03-03 2008-09-15 Veridex Llc Prueba molecular para predecir la recurrencia del cancer de colon de la etapa b de duke.
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2530167A1 (en) 2006-05-11 2012-12-05 Raindance Technologies, Inc. Microfluidic Devices
US9074242B2 (en) 2010-02-12 2015-07-07 Raindance Technologies, Inc. Digital analyte analysis
EP3536396B1 (en) 2006-08-07 2022-03-30 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
CN101631454A (zh) 2006-12-08 2010-01-20 衣阿华州立大学研究基金公司 参与硝酸盐吸收和代谢的植物基因
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
EP2328911A4 (en) 2008-09-22 2012-03-14 Cedars Sinai Medical Center SHORT HUMAN MD-2 AS A NEGATIVE REGULATOR OF GREAT LIKE RECEPTOR 4 SIGNALING
US9512196B2 (en) 2008-09-22 2016-12-06 Cedars-Sinai Medical Center Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
US9207242B2 (en) * 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
NZ608153A (en) * 2010-09-13 2014-12-24 Clinical Genomics Pty Ltd Epigenetic markers of colorectal cancers and diagnostic methods using the same
EP2622103B2 (en) 2010-09-30 2022-11-16 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
WO2012109600A2 (en) 2011-02-11 2012-08-16 Raindance Technologies, Inc. Methods for forming mixed droplets
EP3736281A1 (en) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
EP2714970B1 (en) 2011-06-02 2017-04-19 Raindance Technologies, Inc. Enzyme quantification
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US20130210659A1 (en) 2012-02-10 2013-08-15 Andrew Watson Molecular diagnostic screening assay
EP2844768B1 (en) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digital analyte analysis
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US20160116474A1 (en) * 2013-06-20 2016-04-28 The Broad Institute, Inc. Compositions and methods for detecting and treating glioblastoma
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
CN106086220A (zh) * 2016-08-19 2016-11-09 浙江省中医院 一种非小细胞肺癌单核苷酸多态性检测试剂盒及其应用
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
EP3792363B1 (en) 2018-01-23 2024-06-26 Excellen Medical Technology Co., Ltd. Method and kit for identifying lung cancer status

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US6350576B1 (en) * 1994-12-20 2002-02-26 Cold Spring Harbor Laboratory Cancer detection probes
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US6275814B1 (en) * 1996-11-27 2001-08-14 Investment Strategies Network Investment portfolio selection system and method
US6003018A (en) * 1998-03-27 1999-12-14 Michaud Partners Llp Portfolio optimization by means of resampled efficient frontiers
MXPA01009369A (es) 1999-03-15 2003-06-06 Eos Biotechnology Inc Nuevos metodos para el diagnostico del cancer colorectal, composiciones, y metodos para seleccionar moduladores del cancer colorectal.
US6175824B1 (en) * 1999-07-14 2001-01-16 Chi Research, Inc. Method and apparatus for choosing a stock portfolio, based on patent indicators
AU780829B2 (en) * 1999-07-15 2005-04-21 Research Development Foundation Corticotropin releasing factor receptor 2 deficient mice and uses thereof
US6221600B1 (en) * 1999-10-08 2001-04-24 Board Of Regents, The University Of Texas System Combinatorial oligonucleotide PCR: a method for rapid, global expression analysis
JP2004509629A (ja) * 2000-09-19 2004-04-02 ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ 腫瘍に対する遺伝子マーカー
JP2005508135A (ja) * 2001-03-09 2005-03-31 ニューゲン テクノロジーズ, インコーポレイテッド Rna配列の増幅のための方法および組成物
CA2450379A1 (en) * 2001-06-10 2002-12-19 Irm Llc Molecular signatures of commonly fatal carcinomas
US7348142B2 (en) * 2002-03-29 2008-03-25 Veridex, Lcc Cancer diagnostic panel

Similar Documents

Publication Publication Date Title
JP2004033215A5 (ja)
CN108048466A (zh) CRISPR-Cas13a系统特异性靶向人RSPO2基因的crRNA及系统和应用
JP2008526249A5 (ja)
JP2009543552A5 (ja)
US11053551B2 (en) Method and apparatus for determining a probability of colorectal cancer in a subject
JP2010535782A5 (ja) メチルトランスフェラーゼを標的にすることによるメチル化を元に戻す方法
WO2005106026B1 (en) Use of genes as molecular markers in diagnosis of schizophrenia and diagnostic kit for the same
JP2003325192A5 (ja)
BRPI0614445B8 (pt) ensaio de ácido nucleico para resistência de fármaco de equinocandina em fungos suscetíveis aos fármacos de equinocandina e contendo o gene fks1 que corresponde a subunidade fks1p 1,3-?-d-glicano sintase, bem como conjunto de oligonucleotídeos e kit de reagentes de amplificação
JP2003325191A5 (ja)
ITVT20110002A1 (it) Metodo di determinazione dell'origine di fluidi o tracce biologiche e kit di reagenti per la loro identificazione in un campione.
KR102414106B1 (ko) 유방암 진단용 다중 바이오마커 및 이의 용도
JP2009511026A5 (ja)
JP2003325190A5 (ja)
Yoo et al. H‐ras and K‐ras mutations in soft tissue sarcoma: Comparative studies of sarcomas from Korean and American patients
CN107177676A (zh) 长链非编码rna nonhsat113026用于肾癌诊断分子标志物的用途
DE60136746D1 (de) Oligonucleotide zur markierung von oligonukleotidsonden und proteine
JP2007527241A5 (ja)
CN106544437B (zh) 一种检测白血病融合基因的多重荧光pcr试剂盒
KR20220116931A (ko) 대장암 및 대장 용종 선별 방법 및 그 응용
Verstovsek et al. Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia
KR101975412B1 (ko) 핵산 효소를 이용한 전립선암 바이오마커의 검출용 프라이머 세트, 검출용 조성물 및 이를 이용한 전립선암 바이오마커의 검출 방법
CN202022938U (zh) 基因群检测结构
JP2007532142A (ja) 乳がん遺伝子発現バイオマーカー
KR102548873B1 (ko) 대장암 및 진행 선종의 선별 검사 방법 및 그 응용